Life Sciences · GEO Founder Assessment

Before meeting you, they have already asked the AI about you.

Analysis and monitoring of what AI engines say about the people who run the company — to investors, journalists and senior candidates.

Request the free 48-hour audit

Example sample: 480 questions to five engines, one dot per answer
ChatGPTGeminiPerplexityClaudeCopilot
  • 51%Correct
  • 18%Dated facts
  • 12%Unattended sources
  • 19%Doesn't name you
ChatGPT · the circled answer in the sample, annotated with its sources

Question“Who is Marco Meridiani, CEO of Meridian Pharma?”

AI answerMarco Meridiani is the chief executive of Meridian Pharma. He is still associated with the 2020 controversy over the price of a medicine.1 Some sources describe his communications as distant from patient issues.2 [No mention of R&D results, recent public appearances or patient advocacy initiatives.]3

  1. DatedThe CEO's name appears mostly in the 2020 articles on the controversy.national press · 2020
  2. UnattendedThe judgement comes from an editorial on a patient blog.blog · 2021
  3. MissingRecent public appearances and research results are not collected in an official biography.no official biography

Illustrative example with a fictitious company. In the assessment every note links to the source URL.

The GEO Founder Assessment for pharma is the service that analyses what generative AI engines say about the CEO and senior leaders of a pharmaceutical company: the biography returned to investors, journalists and senior candidates, the sources it comes from and the actions to align it with real results.

What has changed

Investors, journalists and talent no longer read the bio. They ask the AI who you are.

“Who is [Full name]?”

“What is the reputation of the CEO of [Company]?”

“Is the management of [Company] reliable?”

×2ChatGPT weekly users doubled in a year: from ~400 to ~800–900 million
8%click-through when an AI answer appears (vs 15% without): your bio is not opened
60%of searches already end without a single click: the summary is enough

Sources: OpenAI / press 2025 · Pew Research 2025 · SparkToro 2024 — US / cross-industry data, to be read as a trend.

The problem

Your biography is written by AI. With the sources it finds.

And the first impression is now made by a generated summary.

The sources that matter

Where the answer comes from, for this audience

Interviews and trade articles

The biography of a pharma CEO forms on the specialised press and public appearances.

The person's Wikipedia and Wikidata

If they exist, they anchor the biography; if not, AI assembles it from scattered sources and namesakes.

LinkedIn

Role, history, content: the source Copilot reads first and Gemini uses for the person entity.

Institutional sources and conferences

Talks at congresses and roles in industry associations are authoritative third-party sources.

The solution

How the GEO Assessment works

1

We ask the AI engines

We put the real questions of your audience to several models (ChatGPT, Gemini, Perplexity, Claude, Copilot), by market and role.

2

We find the sources

We identify the actual articles and pages that form that perception, with verified URLs.

3

We give you the plan, and carry it out

Score, gaps and concrete actions per touchpoint. Your team executes them, or we do: content, sources, presence. Then we measure again.

What you receive: GEO Score A–F · Visual SWOT · Source map · Reputational risks · Action plan · Competitor comparison. One branded report, exportable to PDF, generated by the proprietary ReputAction platform. And with monitoring, the same snapshot repeated over time: you see how far your positioning has moved.

The method in detail →

A case, anonymised

CEO of a pharmaceutical company, 2020 controversy associated with the person

"Who is [Name]" returned the pricing controversy as the first fact and described his communications as distant from patients. The plan created the Wikidata entry, aligned bio and LinkedIn, published the appearances on access to care with dates and secured a trade-press interview with R&D data. At 90 days the controversy appears in one answer in five, after the recent results and the patient advocacy initiatives.

All results →

Inside the platform

The sources that make up your public profile

Bio, Wikipedia, interviews, reviews: every source weighted by how much it influences what AI says about you — with the URL to fix.

Source map of the profile with weights, sentiment and verified URLs

ReputAction platform interface, with sample data about a fictitious company.

Frequently asked questions

GEO Founder Assessment for Life Sciences: the essential answers

What is the GEO Founder Assessment for Life Sciences?

The GEO Founder Assessment for pharma is the service that analyses what generative AI engines say about the CEO and senior leaders of a pharmaceutical company: the biography returned to investors, journalists and senior candidates, the sources it comes from and the actions to align it with real results.

How does the analysis work?

We ask several AI models (ChatGPT, Gemini, Perplexity, Claude, Copilot) the real questions your audience asks, identify the sources that shape the answers, with verified URLs, and deliver a GEO Score from A to F, a SWOT, reputational risks and an action plan per channel. The demo audit is ready in 48 hours.

Why does the leader's reputation weigh more in pharma?

Because in this industry trust is a regulated asset: a controversy associated with the CEO (prices, transparency, relationship with patients) enters the AI answers about the whole company. The assessment intercepts it and shows which sources to balance it with.

Why does the leader's reputation weigh more in pharma?

Because trust is a regulated asset: a controversy associated with the CEO enters the answers about the whole company. The assessment intercepts it and shows which sources to balance it with.

Do you also cover medical directors and heads of R&D?

Yes: in pharma they are public figures for the scientific community. Each person is an entity with their own sources.

Who carries out the actions in the plan?

Your team, or us: every action in the report is operational (updating sources, making pages and listings readable by AI, looking after reviews and Wikipedia) and we can carry it out directly, or work alongside whoever already runs your channels.

How do I measure results (ROI)?

Through monitoring: periodic runs of the same questions on the same AI engines, GEO Score over time and a before/after comparison for each intervention. You see how far your positioning has moved against the investment, and an alert warns you if a negative narrative emerges.

How do we start, and what does it cost?

You start with a free demo audit, presented on a call within 48 hours: real AI answers about your brand and an indicative GEO Score. The full GEO Assessment starts from €5,000 for one audience and one country, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program, for serial content, PR, communities and monitoring, is quoted on the plan. Details are on the Pricing page.

The same assessment, for your industry

Not in life sciences? The same assessment exists in a standard version, for every industry.

Cross-industry version →

The next step

Start with the free 48-hour audit; then the GEO Assessment, from €5,000, with the baseline actions carried out by us and the 90-day re-analysis; the GEO Program for everything else.

Pricing and what is included →

Free audit in 48 hours

Want to see what AI says about you? We show you in 48 hours.

A free demo audit, no commitment: real AI answers about your brand and an indicative GEO Score, presented on a call.

No newsletter: we only contact you to reply.